(Q35085486)

English

Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

0 references

25

object named as

Reed A Omary

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Riad Salem

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Robert J Lewandowski

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Laura Kulik

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Edward Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Ahsun Riaz

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Robert K Ryu

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Kent T Sato

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Ramona Gupta

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Paul Nikolaidis

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Frank H Miller

10

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Vahid Yaghmai

11

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Saad M Ibrahim

12

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Seanthan Senthilnathan

13

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Talia Baker

14

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Vanessa L Gates

15

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Bassel Atassi

16

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Steven Newman

17

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Khairuddin Memon

18

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Richard Chen

19

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Robert L Vogelzang

20

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Albert A Nemcek

21

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Scott A Resnick

22

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Howard B Chrisman

23

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

James Carr

24

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Michael Abecassis

26

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Al B Benson

27

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Mary F Mulcahy

28

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

30 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

140

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

497-507.e2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

What is evidence?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Comparative effectiveness research: Policy context, methods development and research infrastructure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Does comparative-effectiveness research threaten personalized medicine?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

NCCN clinical practice guidelines in oncology: hepatobiliary cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Clinical trials are often false positive: a review of simple methods to control this problem

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Management of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Chemoembolization for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Hepatocellular carcinoma and hepatitis C in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

8 July 2018

On the limitations of comparative effectiveness research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

27 September 2018

Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

27 September 2018

The effect of doxorubicin on the changes of serum vascular endothelial growth factor (VEGF) in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization (TACE).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

27 September 2018

Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

27 September 2018

[The problem of multiple testing and solutions for genome-wide studies].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

27 September 2018

Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

27 September 2018

Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129335

27 September 2018

New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21044630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres

1 reference

https://pubmed.ncbi.nlm.nih.gov/21044630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization

1 reference

https://pubmed.ncbi.nlm.nih.gov/21044630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/21044630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effectiveness research: what it means for radiology

1 reference

https://pubmed.ncbi.nlm.nih.gov/21044630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A retrospective comparative analysis of the effect of Y90-radioembolization on the survival of patients with unresectable hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21044630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Charting a path from comparative effectiveness funding to improved patient-centered health care

1 reference

https://pubmed.ncbi.nlm.nih.gov/21044630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy, effectiveness, and comparative effectiveness in liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21044630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1053/J.GASTRO.2010.10.049

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35085486&oldid=1962779981"